Status: Recruiting
High Coverage CARotid Stenting vs. Medical Management Alone to Prevent EmboliSm From symptomaTic Non-stenotic cARotid Disease (SyNC)
Goal is to analyse the clinical safety and efficacy of the CARESTO® heal Stent within standard clinical routine for the treatment of patients with symptomatic non-stenotic carotid disease (SyNC) and with high-risk plaque features for stroke recurrence compared to medical treatment alone with respect to the mid- and long-term clinical outcomes.
Participants needed: 536
Trial details
Age: 18+Biological sex: AllType: ObservationalSponsor: Acandis GmbHUpdated: Mar 4, 2026Locations: 1
Eligibility criteria
Patients diagnosed with acute ischemic stroke or acute retinal artery ischemia w... [+13]
Patients with acute complete occlusion of the carotid artery in an emergency set... [+17]